| MicroRNA in disease regulation | Lifetime | 597 | CN 218 | 98.11 |
| Circular RNAs in diseases | Lifetime | 326 | CN 176 | 97.87 |
| Cancer-related molecular mechanisms research | Lifetime | 883 | CN 402 | 97.66 |
| Inflammasome and immune disorders | Lifetime | 238 | CN 14 | 97.54 |
| Autophagy in Disease and Therapy | Lifetime | 515 | CN 79 | 96.80 |
| Berberine and alkaloids research | Lifetime | 156 | CN 48 | 93.91 |
| NF-κB Signaling Pathways | Lifetime | 652 | CN 45 | 94.70 |
| Histiocytic Disorders and Treatments | Lifetime | 561 | CN 19 | 88.08 |
| Biomarkers in Disease Mechanisms | Lifetime | 694 | CN 55 | 83.22 |
| Medicinal Plant Pharmacodynamics Research | Lifetime | 505 | CN 333 | 77.14 |
| Inflammation biomarkers and pathways | Lifetime | 997 | CN 174 | 67.62 |
| Biological Stains and Phytochemicals | Lifetime | 757 | CN 134 | 48.18 |
| Immune Cell Function and Interaction | 2021-2025 | 213 | CN 47 | 96.78 |
| Autophagy in Disease and Therapy | 2021-2025 | 99 | CN 45 | 95.78 |
| Cancer-related molecular mechanisms research | 2021-2025 | 387 | CN 296 | 96.84 |
| Inflammasome and immune disorders | 2021-2025 | 113 | CN 56 | 95.21 |
| Epigenetics and DNA Methylation | 2021-2025 | 360 | CN 135 | 94.56 |
| Head and Neck Cancer Studies | 2021-2025 | 220 | CN 51 | 96.46 |
| Acute Myeloid Leukemia Research | 2021-2025 | 372 | CN 17 | 96.64 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 350 | CN 149 | 92.45 |
| Cardiac Ischemia and Reperfusion | 2021-2025 | 53 | CN 14 | 94.21 |
| Acute Lymphoblastic Leukemia research | 2021-2025 | 340 | CN 19 | 94.54 |
| Histiocytic Disorders and Treatments | 2021-2025 | 24 | CN 4 | 92.64 |
| Nutrition and Health in Aging | 2021-2025 | 735 | CN 96 | 92.93 |
| Anesthesia and Neurotoxicity Research | 2021-2025 | 172 | CN 55 | 90.15 |
| interferon and immune responses | 2021-2025 | 375 | CN 204 | 88.63 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 606 | CN 70 | 92.12 |
| Cancer Cells and Metastasis | 2021-2025 | 703 | CN 140 | 86.50 |
| Hematopoietic Stem Cell Transplantation | 2021-2025 | 549 | CN 46 | 91.26 |
| Retinoids in leukemia and cellular processes | 2021-2025 | 121 | CN 23 | 84.19 |
| Head and Neck Surgical Oncology | 2021-2025 | 611 | CN 62 | 86.17 |
| Parvovirus B19 Infection Studies | 2021-2025 | 166 | CN 27 | 83.51 |
| Viral-associated cancers and disorders | 2021-2025 | 507 | CN 104 | 85.63 |
| Cancer Mechanisms and Therapy | 2021-2025 | 466 | CN 190 | 81.48 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 966 | CN 196 | 82.70 |
| NF-κB Signaling Pathways | 2021-2025 | 122 | CN 43 | 72.80 |
| Cancer Research and Treatments | 2021-2025 | 1,000 | CN 427 | 77.75 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 725 | CN 92 | 77.69 |
| Immune Response and Inflammation | 2021-2025 | 926 | CN 368 | 74.99 |
| CNS Lymphoma Diagnosis and Treatment | 2021-2025 | 517 | CN 49 | 78.15 |
| Cancer, Stress, Anesthesia, and Immune Response | 2021-2025 | 321 | CN 125 | 74.89 |
| Management of metastatic bone disease | 2021-2025 | 726 | CN 81 | 74.74 |
| Cytokine Signaling Pathways and Interactions | 2021-2025 | 668 | CN 201 | 71.64 |
| Cell death mechanisms and regulation | 2021-2025 | 270 | CN 73 | 69.52 |
| Enhanced Recovery After Surgery | 2021-2025 | 756 | CN 79 | 68.88 |
| Tumors and Oncological Cases | 2021-2025 | 678 | CN 58 | 66.76 |
| Traditional Chinese Medicine and Integrative Care | 2021-2025 | 202 | CN 125 | 67.30 |
| Berberine and alkaloids research | 2021-2025 | 313 | CN 181 | 61.51 |
| Syphilis Diagnosis and Treatment | 2021-2025 | 785 | CN 107 | 62.58 |
| Amino Acid Enzymes and Metabolism | 2021-2025 | 856 | CN 216 | 56.47 |
| Advances in Cucurbitaceae Research | 2021-2025 | 576 | CN 204 | 57.07 |
| Calcium signaling and nucleotide metabolism | 2021-2025 | 473 | CN 81 | 53.25 |
| Vascular Malformations and Hemangiomas | 2021-2025 | 934 | CN 184 | 54.44 |
| Intestinal and Peritoneal Adhesions | 2021-2025 | 929 | CN 120 | 48.55 |
| Wnt/β-catenin signaling in development and cancer | 2021-2025 | 907 | CN 261 | 43.25 |
| Medicinal Plants and Bioactive Compounds | 2021-2025 | 947 | CN 422 | 29.60 |
| Phytochemistry and Bioactive Compounds | 2021-2025 | 694 | CN 276 | 24.36 |
